{"groups":[{"description":"aprepitant plus standard anti-emetic regimen\n\nAprepitant: Add aprepitant to anti-emetic regimen","id":"FG000","title":"Aprepitant"},{"description":"olanzapine plus standard anti-emetic regimen\n\nOlanzapine: add olanzapine to anti-emetic regimen","id":"FG001","title":"Olanzapine"},{"description":"aprepitant and olanzapine plus standard anti-emetic regimen\n\nAprepitant plus Olanzapine: add aprepitant and olanzapine to anti-emetic regimen","id":"FG002","title":"Aprepitant Plus Olanzapine"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"1"}],"type":"met exclusion criteria"},{"reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"0"}],"type":"Did not complete survey"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"0"}],"type":"Withdrawal by Subject"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"18"},{"groupId":"FG001","numSubjects":"25"},{"groupId":"FG002","numSubjects":"9"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"14"},{"groupId":"FG001","numSubjects":"21"},{"groupId":"FG002","numSubjects":"8"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"4"},{"groupId":"FG001","numSubjects":"4"},{"groupId":"FG002","numSubjects":"1"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}